baber/WOPTO huggingface dataset:
Patent CA-3126229-A1 (CA)
Title: Control node with an octagonal vector constellation for an array antenna
Inventor: ADAM THIERRY
IPC: H04B1/04
Filed: 2021-07-28
Abstract: The invention relates to a control node for an array antenna (103) configured so as to apply an attenuation and a phase shift to a radiofrequency signal on the basis of a control signal, to a beamforming network, to an array antenna and to a satellite comprising the control node. It comprises -    a quadratic divider (301) that delivers an in-phase signal and a quadrature signal on separate transmission channels, -    a combiner (306) configured so as to sum the signals transmitted on two of the transm ission channels, each transmission channel comprising at least: -    one attenuation cell (302, 303) activated on the basis of the value of a dedicated bit (310, 311) of the control signal, and -    one phase shift cell (501, 502) configured so as to apply a fixed phase shift, activated on the basis of the result of combinational logic (503, 504) implemented on bits of the control signal (312, 313).
Patent CA-3127056-A1 (CA)
Inventor: GU JIAXIU
IPC: G06Q20/40
Filed: 2021-09-17
Abstract: The present invention discloses one face recognition method, device and computer readable storage medium, the method includes: obtain user's face image, request to initiate the first match and output the first comparison result; And judging whether to initiate the second match request and output the second comparison result according to the first comparison result; If the first comparison result and the second comparison result meet the comparison requirement, copying the face image that meets the comparison requirement to the first face database. The present invention uses the verification program of the failed face recognition and the copying program of the face image to solve the problem that the user has always failed to recognize and cannot make face payment, which achieves the fast face comparison and reduces the cost of data maintenance.
Patent CA-3127267-A1 (CA)
Title: Transverse bar and chain link with transverse bar
Inventor: THEISS GEORG
IPC: F16G13/16
Filed: 2020-01-23
Abstract: The invention relates to a crossbar (4) for detachably connecting two lateral parts (3) of a chain link (2) of a cable carrier chain, the crossbar having, at least at one or at both of its ends, an attachment region (7) for releasable attachment to the particular lateral part, and the attachment region of the crossbar comprising a locking element (8) which can be moved to a locking position and to an unlocking position, wherein in the locking position the crossbar is non-releasably locked to the lateral part, and in the unlocking position the crossbar can be released from the lateral part, wherein the locking element comprises an actuating portion for selectively moving the locking element to its locking or unlocking position, as well as a locking portion for locking engagement with the lateral part. The locking element is designed as a pivot part, and when the locking element is actuated, the locking portion is moved, at least in one component of its movement, from the locking position to its unlocking position or vice versa in a pivot movement.
Patent CA-3127645-A1 (CA)
Title: Dna-encoded bispecific t-cell engagers targeting cancer antigens and methods of use in cancer theraputics
Inventor: MUTHUMANI KAR
IPC: A61K35/28
Filed: 2020-01-30
Abstract: Disclosed herein are compositions comprising a recombinant nucleic acid sequence encoding a bispecific immune cell engaging antibody (DICE), a recombinant nucleic acid sequence encoding a bispecific T cell engaging (DBiTE) antibody, a fragment thereof, a variant thereof, or a combination thereof.
Patent CA-3131316-A1 (CA)
Inventor: HONDA KENYA
IPC: A61P31/04
Filed: 2020-03-06
Abstract: Disclosed herein are bacteriophage compositions and therapeutic uses thereof. The disclosure also relates to bacteriophage that are capable of lysing Klebsiella bacterial strains, e.g., strains that are associated with inflammatory bowel disease, and thereby capable of modulating disease.
Patent CA-3133343-A1 (CA)
Title: Virage a droite protege
Inventor: CROSS BRAD
IPC: G08G1/07
Filed: 2020-03-05
Abstract: La présente invention concerne des systèmes et des procédés pour un système de commande d'une grille de circulation, le système comprenant une grille de circulation comprenant une première route et une seconde route, la seconde route croisant la première route au niveau d'une intersection ; une voie de transit spéciale incluse à l'intérieur d'au moins une parmi la première route et la seconde route, la voie de transit spéciale étant configurée pour partager à la fois la circulation de véhicule personnel et la circulation de véhicule spécial ; un détecteur configuré pour détecter la présence d'un véhicule spécial dans une zone de détection, ladite zone de détection étant formée à l'intérieur de la voie de transit spéciale dans une zone prédéterminée à proximité de l'intersection ; et une lumière de signal à proximité de l'intersection configurée pour commander le déplacement de la circulation à travers l'intersection, la lumière de signal ayant un dispositif de commande ; le dispositif de commande commandant la lumière de signal de fonctionner dans un premier mode de fonctionnement sur la base, au moins en partie, d'une détection d'un véhicule spécial par le détecteur à l'intérieur de la zone de détection.
Patent CA-3134733-A1 (CA)
Title: Procede et dispositif de fonctionnement automatique d'une installation de transport a bande utilisee en particulier dans une exploitation a ciel ouvert
Inventor: NARO DANIELE
IPC: B65G43/00
Filed: 2020-03-20
Abstract: L'invention concerne un procédé et un dispositif de fonctionnement d'une installation de transport comprenant au moins deux appareils d'extraction et/ou de transport (100, 105, 120) pour évacuer un matériau en vrac extrait sur un site d'extraction (147). Entre les au moins deux appareils d'extraction ou de transport (100, 105, 120) sont disposés des points de transfert (165, 170) pour transférer le matériau extrait. L'invention prévoit notamment que les positions et/ou orientations spatiales d'au moins deux appareils d'extraction ou de transport (100, 105, 120) impliqués dans un point de transfert respectif soient déterminées par capteur (180, 185, 190, 195, 197) et que les au moins deux appareils d'extraction ou de transport (100, 105, 120) impliqués dans le point de transfert respectif (165, 170) puissent être commandés d'après les positions ou orientations spatiales déterminées (215) de façon à adapter les positions ou orientations des au moins deux appareils de transport ou d'extraction (100, 105, 120) dans la zone du point de transfert respectif (165, 170).
Patent CA-3135489-A1 (CA)
Inventor: KAPOOR NEERAJ
IPC: A61K39/02
Filed: 2020-03-27
Abstract: The present disclosure provides a cell-free method for synthesizing an Invasion Plasmid Antigen B (IpaB) antigen associated with a Shigella bacterium comprising exogenous addition of the purified chaperone protein IpgC to the cell-free synthesis mixture. The disclosure further provides IpaB antigen mutants comprising non-natural amino acids incorporated during cell-free synthesis, enabling covalent conjugation to a Shigella O-antigen polysaccharide. Further provided are Ipa B antigens and conjugates thereof, as well as immunogenic compositions prepared with the synthesized IpaB antigens and conjugates thereof and methods of use.
Patent CA-3136141-A1 (CA)
Title: Vaccins contre le circovirus porcin de type 3 (pcv3), sa production et ses utilisations
Inventor: IYER ARUN
IPC: A61K39/12
Filed: 2020-04-06
Abstract: La présente invention concerne l'utilisation d'une composition immunogène qui comprend un antigène de circovirus porcin de type 3 (PCV3) pour le traitement de plusieurs manifestations cliniques (maladies). De préférence, les manifestations cliniques sont associées à une infection à PCV3.
Patent CA-3141263-A1 (CA)
Inventor: RAMO VIRPI
IPC: H01B3/22
Filed: 2020-07-22
Abstract: An electrotechnical fluid composition, comprising more than 90 wt-% paraffins in the C17- C18 range, based on the total weight of the composition, is described. The ratio of the amount of C18 i-paraffins to the amount of C18 n- paraffins is more than 40, based on the weight of the C18 i-paraffins and the weight of the C18 n-paraffins in the composition.
Patent CA-3143329-A1 (CA)
Title: Valves and control systems for pressure equalization and de-energization
Inventor: FINK DANIEL
IPC: F16K17/168
Filed: 2020-06-15
Abstract: A pressure control system configured to automatically monitor and control pressure in fluid lines used in hydraulic fracturing or well stimulation activities is disclosed. The system generally includes at least two valve assemblies each having a valve and a valve actuation system, at least one pressure sensor, and an electro-mechanical control package. These components are configured such that the electro-mechanical controls automate the open and closed positions of the valve(s) via operation of the actuator(s) based on user inputs and information from the pressure sensor. This architecture allows the system to monitor and interpret pressures within the conduit and operate the valve position based on user defined signals and set-points. The valves may be positioned to redundantly monitor the same fluid conduit, or separate fluid conduits, and the system may be configured to enable independent valve positions based on independent user defined set-points or user inputted control signals.
Patent CA-3144275-A1 (CA)
Title: Adaptive control of medical devices based on clinician interactions
Inventor: NESTERENKO IGOR
IPC: G16H40/60
Filed: 2020-06-24
Abstract: A method and system identifies interactions of a user with one or more medical devices, determines, based on the one or more interactions and a predetermined set of rules, a compliance score associated with the first user, in response to the compliance score not satisfying a threshold compliance score, and reducing an access level of the user to at least one of the one or more medical devices and generates a training program associated with the at least one medical device and the one or more interactions, and automatically, without user involvement, sends a training package associated with the training program to the user and notifies the user to complete the training program using the training package. The system and method also generates a new shift schedule for clinicians responsive to a first shift schedule not satisfying criteria and the clinicians not satisfying respective performance scores.
Patent CA-3146297-A1 (CA)
Title: Detection d'impulsion neuronale en temps reel
Inventor: KOH THONG-WEI
IPC: G06F9/00
Filed: 2020-07-09
Abstract: L'invention concerne un procédé de détection et de classification en temps réel d'un signal caractéristique, tel qu'une impulsion neuronale, et de transmission d'informations pour un traitement ultérieur s'il satisfait à certains critères. Un système (par exemple, un système sur puce doté d'une puissance de traitement limitée implanté dans le crâne d'un sujet) reçoit un signal biologique électrique. Le système filtre le signal pour générer un signal filtré et ajuste le signal filtré à un modèle. Le système identifie un ensemble de valeurs d'ajustement sur la base du modèle, l'ensemble de valeurs d'ajustement comprenant une pluralité de valeurs d'amplitude d'échantillon et une pluralité correspondante de valeurs temporelles. Sur la base des valeurs d'ajustement, le système calcule un ensemble de valeurs caractéristiques. Le système compare les valeurs caractéristiques à un ensemble correspondant de valeurs seuils. Sur la base de la comparaison, le système détermine si le signal biologique reçu correspond à une impulsion neuronale et, si une impulsion est détectée, transmet des informations.
Patent CA-3154733-A1 (CA)
Title: Process for producing tungsten metal powders
Inventor: SAEUBERLICH TINO
IPC: B22F9/20
Filed: 2020-12-14
Abstract: The invention relates to a process for producing tungsten metal powders by reduction of tungsten oxide, characterized in that the properties of the metal powder obtained are continuously monitored in and during the process.
Patent CA-3154984-A1 (CA)
Title: Apparatus and method for photobiomodulation-based alternative to electrical vagus nerve stimulation and deep brain stimulation related to movement disorders
Inventor: LIM LEW
IPC: A61N5/06
Filed: 2020-10-27
Abstract: A self-administrable apparatus for performing non-invasive neurostimulation therapy of a living mammal on-demand, said self-administrable non-invasive neurostimulation apparatus comprising: one or more configured irradiation units comprising a portable hollow casing having fixed dimensions, a sized internal spatial volume and an external surface configuration suitable for application to a body, and a controller assembly able to control on-demand delivery of light energy from said configured irradiation units into an interior part of the body in-vivo.
Patent CA-3157928-A1 (CA)
Inventor: ATALLAH RYAN ANDREW
IPC: G06F16/22
Filed: 2020-09-30
Abstract: A method prepares data for subsequent analysis. The method obtains a data model that encodes a data sources as a tree of logical tables. Each logical table has its own physical representation and includes logical fields. Each logical field corresponds to either a data field or a calculation that spans logical tables. The method associates each logical table in the data model with a corresponding concept in a concept graph. The concept graph embodies hierarchical inheritance of semantics. For each logical field, the method assigns a semantic role to the logical field based on a concept corresponding to a logical table. The method also validates the logical field based on its semantic role. The method also displays transformations to clean the logical field based on validating the logical field. The method transforms the logical field according to a user selection, and updates the logical table.
Patent CA-3160349-A1 (CA)
Inventor: CARPENTER JUDITH
IPC: A61B17/12
Filed: 2010-01-08
Abstract: There is disclosed a porous emboli deflector (100) for preventing cerebral emboli while maintaining cerebral blood flow during an endovascular or open surgical procedure. The device prevents the entrance of emboli of a size able to cause stroke (such as greater than 100 microns) from entering either the right (22) or left (24) common carotid arteries by deflecting emboli downstream of these vessels. The device (100) can be placed prior to any manipulation of the heart or aorta (10) allowing maximal protection of the brain during the index procedure. The deflector (100) has a low profile within the aorta (10) which allows sheaths, catheters, or wires used in the index procedure to pass. Also disclosed are methods for insertion and removal of the deflector (100).
Patent CA-3160434-A1 (CA)
Inventor: WANG SAMANTHA CHEN-YEE
IPC: A61C19/06
Filed: 2020-11-23
Abstract: L'inventioin concerne des dispositifs comprenant un ou plusieurs symboles indicateurs de dosage pour signaler à un utilisateur la quantité de matériau qui devrait être distribuée. Elle concerne aussi un stylo de blanchiment avec un premier indicateur de dosage sur le corps et un second indicateur de dosage sur la partie rotative qui peuvent permettre à un utilisateur de distribuer une quantité connue d'une composition de blanchiment.
Patent CA-3160575-A1 (CA)
Inventor: OLSSON JOHAN
IPC: C08B37/08
Filed: 2020-12-01
Abstract: Described are high molecular weight glycosaminoglycan (GAG) hydrogel compositions comprising GAGs covalently crosslinked with a carbohydrate crosslinker, and methods of making the high molecular weight GAG hydrogel compositions. Further described are methods of using the high molecular weight glycosaminoglycan (GAG) hydrogel compositions for reparative or plastic surgery, esthetic dermatology, facial contouring, body contouring, and gingival augmentation.
Patent CA-3163186-A1 (CA)
Title: Metal reinforced board
Inventor: KALL HAKAN
IPC: B32B3/06
Filed: 2020-12-08
Abstract: The invention relates to a hollow board material comprising a first sheet and a second sheet. A first and a second lath are arranged in parallel between the first sheet and the second sheet along opposite edges of the hollow board material. The first lath and the first sheet are attached to each other by means of a first metal gripping lamina which at least partly covers the first lath. The second lath and the first sheet are attached to each other by means of a second metal gripping lamina which at least partly covers the first lath. Optionally, the first lath and the second sheet are attached to each other by means of a third metal gripping lamina and optionally the second lath and the second sheet are attached to each other by means of a fourth metal gripping lamina. The metal gripping laminas have a first face and a second face which are opposed to each other. Each face comprises a plurality of sharp projections extending substantially perpendicular therefrom and into the laths or the sheets respectively. The metal gripping laminas thereby provides a hollow board material and increases the bending strength of the hollow board material. The invention further relates to a furniture comprising said hollow board material and method for producing said hollow board material.
Patent CA-3164219-A1 (CA)
Inventor: BOGDANOVICH PHILLIP
IPC: A42B3/04
Filed: 2020-12-24
Abstract: An intelligent wearable device is disclosed. The intelligent wearable device is configured to monitor and obtain biological data associated with a user wearing the device and environmental data associated with an environment that the user is located in through the use of a plurality of sensors of the wearable device. Once the biological and environmental data are obtained, the intelligent wearable device may compare the data to a threshold value that is associated with the safety of the user. If the comparison indicates that the data is outside the threshold value, the intelligent wearable device may output a signal indicating that the user is experiencing an event. The intelligent wearable device may also generate feedback indicating an action to perform in response to the event. The intelligent wearable device may notify devices associated with other users, who may be able to assist the user experiencing the event.
Patent CA-3167394-A1 (CA)
Inventor: ISABELLA VINCENT M
IPC: C12N1/21
Filed: 2021-02-12
Abstract: The present disclosure provides recombinant bacterial cells that have been engineered with genetic circuitry which allow the recombinant bacterial cells to sense a patient's internal environment and respond by turning an engineered metabolic pathway on or off. When turned on, the recombinant bacterial cells complete all of the steps in a metabolic pathway to achieve a therapeutic effect in a host subject. These recombinant bacterial cells are designed to drive therapeutic effects throughout the body of a host from a point of origin of the microbiome. Specifically, the present disclosure provides recombinant bacterial cells that comprise an amino acid catabolism enzyme, e.g., a methionine catabolism enzyme for the treatment of diseases and disorders associated with amino acid metabolism, including homocystinuria, in a subject. The disclosure further provides pharmaceutical compositions and methods of treating disorders associated with amino acid metabolism, such as homocystinuria.
Patent CA-3167462-A1 (CA)
Title: Methods, systems and compositions using aldehyde for inhibition of melanosis
Inventor: PERKO KATHRYN
IPC: A23L3/3499
Filed: 2021-02-12
Abstract: Disclosed are methods and systems for inhibiting melanosis. The methods comprise the step of placing a melanosis-susceptible object, such as a crustacean or a vegetable, into a closable container or enclosure and exposing the object to aldehyde. In another aspect, disclosed are anti-melanosic articles and polymer compositions that incorporate tea (preferably green tea), matcha or epigallocatechin gallate (EGCG) that function as anti-melanosic agents by releasing aldehyde.
Patent CA-3168209-A1 (CA)
Inventor: YAMASHITA TOSHIHIDE
IPC: C12N15/13
Filed: 2021-01-15
Abstract: L'invention concerne un agent prophylactique ou thérapeutique contre un type de démence choisi parmi la démence diabétique et la démence vasculaire, l'agent contenant une substance inhibitrice de RGMa.
Patent CA-3169527-A1 (CA)
Title: Systeme de verrouillage supraconducteur
Inventor: GALAN ELIAS J
IPC: H03K19/195
Filed: 2021-03-23
Abstract: La présente invention concerne, selon un exemple, un système de verrouillage supraconducteur (50). Le système comprend un premier étage d'entrée (52) qui est configuré pour recevoir une première impulsion d'entrée et un second étage d'entrée (54) qui est configuré pour recevoir une seconde impulsion d'entrée. Le système comprend également une boucle de stockage (60) configurée pour passer d'un premier état à un second état en réponse à la réception de la première impulsion d'entrée, et pour commuter du second état au premier état en réponse à la seconde impulsion d'entrée. Le premier état ne correspond à aucun flux dans la boucle de stockage et le second état correspond à un flux dans la boucle de stockage. Le système comprend en outre un étage de sortie (62) configuré pour générer une impulsion de sortie (PLSout) dans le second état de la boucle de stockage.
Patent CA-3171260-A1 (CA)
Title: Agglomerated dispersible granules, methods for amending soil, and activated alumina suspensions
Inventor: SWISHER HUNTER R
IPC: C05G5/12
Filed: 2021-03-09
Abstract: Agglomerated dispersible granules are disclosed including activated alumina particles and phosphate particles. The activated alumina particles have a porous structure and a plurality of electrically-charged binding sites disposed within the porous structure. The activated alumina particles and the phosphate particles are present in the agglomerated dispersible granules as distinct phases agglomerated together. A method for amending soil with buffered phosphorus is disclosed including physically blending and then agglomerating activated alumina particles with phosphate particles to form the agglomerated dispersible granules. The agglomerated dispersible granules are applied to soil with the activated alumina particles and the phosphate particles being present as distinct phases and the activated alumina particles being free of phosphate disposed within the porous structure. An activated alumina suspension is disclosed including activated alumina particles suspended as a dispersed phase in a continuous phase, the activated alumina particles having a particle size less than 200 µm.
Patent CA-3176718-A1 (CA)
Inventor: MARCANTONIO EUGENE E
IPC: A61P9/10
Filed: 2022-05-19
Abstract: The present disclosure provides a modified-release pharmaceutical composition comprising 4-[(7-methoxy-2,3-dihydro-1,4-benzothiazepin-4(5H)yl)methyllbenzoic acid hemifumarate, and a pharmaceutically-acceptable excipient. The present disclosure methods of treating conditions associated with RyRs, including, for example, cardiac disorder or disease, a musculoskeletal disorder or disease, cancer associated muscle weakness, malignant hyperthermia, and diabetes.
Patent CA-3177163-A1 (CA)
Inventor: YOFFE GIDEON
IPC: G01V1/18
Filed: 2021-04-28
Abstract: Système de détection de fibre distribuée pouvant utiliser un récepteur cohérent intégré. Le récepteur cohérent intégré peut comprendre un circuit d'onde lumineuse plan ayant des trajets de signal optique pour fonctionner séparément sur une entrée de signal et une entrée d'oscillateur local dans un premier état de polarisation et un second état de polarisation, les opérations comprenant le mélange de l'entrée de signal et du signal d'oscillateur local dans le premier état de polarisation, le mélange de l'entrée de signal et du signal d'oscillateur local dans le second état de polarisation, et l'égalisation des signaux mélangés.